<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="blood"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4600016/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600016/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Blood"><meta name="citation_title" content="Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia"><meta name="citation_authors" content="Seth E. Karol, Wenjian Yang, Sara L. Van Driest, Tamara Y. Chang, Sue Kaste, Erica Bowton, Melissa Basford, Lisa Bastarache, Dan M. Roden, Joshua C. Denny, Eric Larsen, Naomi Winick, William L. Carroll, Cheng Cheng, Deqing Pei, Christian A. Fernandez, Chengcheng Liu, Colton Smith, Mignon L. Loh, Elizabeth A. Raetz, Stephen P. Hunger, Paul Scheet, Sima Jeha, Ching-Hon Pui, William E. Evans, Meenakshi Devidas, Leonard A. Mattano, Jr, Mary V. Relling"><meta name="citation_date" content="8 October 2015"><meta name="citation_issue" content="15"><meta name="citation_volume" content="126"><meta name="citation_firstpage" content="1770"><meta name="citation_doi" content="10.1182/blood-2015-05-643601"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4600016/?report=abstract"><meta name="citation_pmid" content="26265699"><meta name="DC.Title" content="Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="The American Society of Hematology"><meta name="DC.Contributor" content="Seth E. Karol"><meta name="DC.Contributor" content="Wenjian Yang"><meta name="DC.Contributor" content="Sara L. Van Driest"><meta name="DC.Contributor" content="Tamara Y. Chang"><meta name="DC.Contributor" content="Sue Kaste"><meta name="DC.Contributor" content="Erica Bowton"><meta name="DC.Contributor" content="Melissa Basford"><meta name="DC.Contributor" content="Lisa Bastarache"><meta name="DC.Contributor" content="Dan M. Roden"><meta name="DC.Contributor" content="Joshua C. Denny"><meta name="DC.Contributor" content="Eric Larsen"><meta name="DC.Contributor" content="Naomi Winick"><meta name="DC.Contributor" content="William L. Carroll"><meta name="DC.Contributor" content="Cheng Cheng"><meta name="DC.Contributor" content="Deqing Pei"><meta name="DC.Contributor" content="Christian A. Fernandez"><meta name="DC.Contributor" content="Chengcheng Liu"><meta name="DC.Contributor" content="Colton Smith"><meta name="DC.Contributor" content="Mignon L. Loh"><meta name="DC.Contributor" content="Elizabeth A. Raetz"><meta name="DC.Contributor" content="Stephen P. Hunger"><meta name="DC.Contributor" content="Paul Scheet"><meta name="DC.Contributor" content="Sima Jeha"><meta name="DC.Contributor" content="Ching-Hon Pui"><meta name="DC.Contributor" content="William E. Evans"><meta name="DC.Contributor" content="Meenakshi Devidas"><meta name="DC.Contributor" content="Leonard A. Mattano, Jr"><meta name="DC.Contributor" content="Mary V. Relling"><meta name="DC.Date" content="2015 Oct 8"><meta name="DC.Identifier" content="10.1182/blood-2015-05-643601"><meta name="DC.Language" content="en"><meta property="og:title" content="Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia"><meta property="og:type" content="article"><meta property="og:description" content="Glucocorticoids are important therapy for acute lymphoblastic leukemia (ALL) and their major adverse effect is osteonecrosis. Our goal was to identify genetic and nongenetic risk factors for osteonecrosis. We performed a genome-wide association study ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600016/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-blood.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4600016/epub/">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE888247DD5830410000000006A003D9.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4600016%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22Blood%22[journal]" class="navlink">Blood</a></li><li class="accid">PMC4600016</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-blood.gif" alt="Logo of blood" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="139,56,200,76" alt="Original Article" title="Original Article" href="http://www.bloodjournal.org/content/126/15/1770" ref="reftype=publisher&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7CArticle%7CFullText" target="pmc_ext"><area shape="rect" coords="0,0,157,57" alt="Blood Journal" title="Blood Journal" href="http://www.bloodjournal.org/" ref="reftype=publisher&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="200,56,258,76" alt="Current Issue" title="Current Issue" href="http://www.bloodjournal.org/content/current" ref="reftype=publisher&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="257,56,311,76" alt="About Blood" title="About Blood" href="http://www.bloodjournal.org/page/about-blood" ref="reftype=publisher&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="309,56,364,77" alt="Submissions" title="Submissions" href="https://submit.bloodjournal.org/" ref="reftype=publisher&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="363,56,420,78" alt="Subscriptions" title="Subscriptions" href="http://www.bloodjournal.org/page/subscriptions" ref="reftype=publisher&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="418,56,476,76" alt="Contact Us" title="Contact Us" href="http://bloodjournal.org" ref="reftype=publisher&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="poly" coords="450,2,431,9,425,27,429,43,437,54,459,55,471,52,483,42,486,29,479,11,466,2,449,2" alt="ASH Homepage" title="ASH Homepage" href="http://www.hematology.org" ref="reftype=publisher&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Blood</a></span>. 2015 Oct 8; 126(15): 1770–1776. </span></div><div><span class="fm-vol-iss-date">Prepublished online 2015 Aug 11. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1182%2Fblood-2015-05-643601" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1182/blood-2015-05-643601</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4600016</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/26265699">26265699</a></div></div></div></div><h1 class="content-title">Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Karol%20SE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585507182128" co-class="co-affbox">Seth E. Karol</a>,<sup>1,</sup><sup>*</sup> <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585497276336" co-class="co-affbox">Wenjian Yang</a>,<sup>2,</sup><sup>*</sup> <a href="/pubmed/?term=Van%20Driest%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585501420032" co-class="co-affbox">Sara L. Van Driest</a>,<sup>3</sup> <a href="/pubmed/?term=Chang%20TY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585498700992" co-class="co-affbox">Tamara Y. Chang</a>,<sup>1</sup> <a href="/pubmed/?term=Kaste%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585501384048" co-class="co-affbox">Sue Kaste</a>,<sup>4,</sup><sup>5</sup> <a href="/pubmed/?term=Bowton%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585500360992" co-class="co-affbox">Erica Bowton</a>,<sup>6</sup> <a href="/pubmed/?term=Basford%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585505568880" co-class="co-affbox">Melissa Basford</a>,<sup>6</sup> <a href="/pubmed/?term=Bastarache%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585508179728" co-class="co-affbox">Lisa Bastarache</a>,<sup>7</sup> <a href="/pubmed/?term=Roden%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585508177744" co-class="co-affbox">Dan M. Roden</a>,<sup>8,</sup><sup>9</sup> <a href="/pubmed/?term=Denny%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585498696672" co-class="co-affbox">Joshua C. Denny</a>,<sup>7,</sup><sup>9</sup> <a href="/pubmed/?term=Larsen%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585497949056" co-class="co-affbox">Eric Larsen</a>,<sup>10</sup> <a href="/pubmed/?term=Winick%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585497947072" co-class="co-affbox">Naomi Winick</a>,<sup>11</sup> <a href="/pubmed/?term=Carroll%20WL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585575635840" co-class="co-affbox">William L. Carroll</a>,<sup>12</sup> <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585506087456" co-class="co-affbox">Cheng Cheng</a>,<sup>13</sup> <a href="/pubmed/?term=Pei%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585501078384" co-class="co-affbox">Deqing Pei</a>,<sup>13</sup> <a href="/pubmed/?term=Fernandez%20CA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585497936544" co-class="co-affbox">Christian A. Fernandez</a>,<sup>2</sup> <a href="/pubmed/?term=Liu%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585497934560" co-class="co-affbox">Chengcheng Liu</a>,<sup>2</sup> <a href="/pubmed/?term=Smith%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585496887472" co-class="co-affbox">Colton Smith</a>,<sup>2</sup> <a href="/pubmed/?term=Loh%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585498986960" co-class="co-affbox">Mignon L. Loh</a>,<sup>14</sup> <a href="/pubmed/?term=Raetz%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585579146416" co-class="co-affbox">Elizabeth A. Raetz</a>,<sup>15</sup> <a href="/pubmed/?term=Hunger%20SP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585497040992" co-class="co-affbox">Stephen P. Hunger</a>,<sup>16</sup> <a href="/pubmed/?term=Scheet%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585497039008" co-class="co-affbox">Paul Scheet</a>,<sup>17</sup> <a href="/pubmed/?term=Jeha%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585492543600" co-class="co-affbox">Sima Jeha</a>,<sup>1</sup> <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585503656688" co-class="co-affbox">Ching-Hon Pui</a>,<sup>1</sup> <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585507785680" co-class="co-affbox">William E. Evans</a>,<sup>2</sup> <a href="/pubmed/?term=Devidas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585500029424" co-class="co-affbox">Meenakshi Devidas</a>,<sup>18</sup> <a href="/pubmed/?term=Mattano%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585500027440" co-class="co-affbox">Leonard A. Mattano, Jr</a>,<sup>19</sup> and  <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699" class="affpopup" co-rid="_co_idm140585498617776" co-class="co-affbox">Mary V. Relling</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140585507182128"><h3 class="no_margin">Seth E. Karol</h3><p><sup>1</sup>Department of Oncology and </p><div>Find articles by <a href="/pubmed/?term=Karol%20SE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Seth E. Karol</a></div></div><div id="_co_idm140585497276336"><h3 class="no_margin">Wenjian Yang</h3><p><sup>2</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Yang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Wenjian Yang</a></div></div><div id="_co_idm140585501420032"><h3 class="no_margin">Sara L. Van Driest</h3><p><sup>3</sup>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN; </p><div>Find articles by <a href="/pubmed/?term=Van%20Driest%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Sara L. Van Driest</a></div></div><div id="_co_idm140585498700992"><h3 class="no_margin">Tamara Y. Chang</h3><p><sup>1</sup>Department of Oncology and </p><div>Find articles by <a href="/pubmed/?term=Chang%20TY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Tamara Y. Chang</a></div></div><div id="_co_idm140585501384048"><h3 class="no_margin">Sue Kaste</h3><p><sup>4</sup>Department of Radiological Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </p><p><sup>5</sup>Department of Radiology, University of Tennessee, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Kaste%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Sue Kaste</a></div></div><div id="_co_idm140585500360992"><h3 class="no_margin">Erica Bowton</h3><p><sup>6</sup>Office of Research, </p><div>Find articles by <a href="/pubmed/?term=Bowton%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Erica Bowton</a></div></div><div id="_co_idm140585505568880"><h3 class="no_margin">Melissa Basford</h3><p><sup>6</sup>Office of Research, </p><div>Find articles by <a href="/pubmed/?term=Basford%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Melissa Basford</a></div></div><div id="_co_idm140585508179728"><h3 class="no_margin">Lisa Bastarache</h3><p><sup>7</sup>Department of Biomedical Informatics, </p><div>Find articles by <a href="/pubmed/?term=Bastarache%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Lisa Bastarache</a></div></div><div id="_co_idm140585508177744"><h3 class="no_margin">Dan M. Roden</h3><p><sup>8</sup>Department of Pharmacology, and </p><p><sup>9</sup>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; </p><div>Find articles by <a href="/pubmed/?term=Roden%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Dan M. Roden</a></div></div><div id="_co_idm140585498696672"><h3 class="no_margin">Joshua C. Denny</h3><p><sup>7</sup>Department of Biomedical Informatics, </p><p><sup>9</sup>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; </p><div>Find articles by <a href="/pubmed/?term=Denny%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Joshua C. Denny</a></div></div><div id="_co_idm140585497949056"><h3 class="no_margin">Eric Larsen</h3><p><sup>10</sup>Department of Pediatrics, Maine Medical Center, Portland, ME; </p><div>Find articles by <a href="/pubmed/?term=Larsen%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Eric Larsen</a></div></div><div id="_co_idm140585497947072"><h3 class="no_margin">Naomi Winick</h3><p><sup>11</sup>Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX; </p><div>Find articles by <a href="/pubmed/?term=Winick%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Naomi Winick</a></div></div><div id="_co_idm140585575635840"><h3 class="no_margin">William L. Carroll</h3><p><sup>12</sup>Department of Pediatrics, New York University Langone Medical Center, New York, NY; </p><div>Find articles by <a href="/pubmed/?term=Carroll%20WL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">William L. Carroll</a></div></div><div id="_co_idm140585506087456"><h3 class="no_margin">Cheng Cheng</h3><p><sup>13</sup>Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Cheng%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Cheng Cheng</a></div></div><div id="_co_idm140585501078384"><h3 class="no_margin">Deqing Pei</h3><p><sup>13</sup>Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Pei%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Deqing Pei</a></div></div><div id="_co_idm140585497936544"><h3 class="no_margin">Christian A. Fernandez</h3><p><sup>2</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Fernandez%20CA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Christian A. Fernandez</a></div></div><div id="_co_idm140585497934560"><h3 class="no_margin">Chengcheng Liu</h3><p><sup>2</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Liu%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Chengcheng Liu</a></div></div><div id="_co_idm140585496887472"><h3 class="no_margin">Colton Smith</h3><p><sup>2</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Smith%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Colton Smith</a></div></div><div id="_co_idm140585498986960"><h3 class="no_margin">Mignon L. Loh</h3><p><sup>14</sup>Department of Pediatrics, University of California School of Medicine, San Francisco, CA; </p><div>Find articles by <a href="/pubmed/?term=Loh%20ML%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Mignon L. Loh</a></div></div><div id="_co_idm140585579146416"><h3 class="no_margin">Elizabeth A. Raetz</h3><p><sup>15</sup>Department of Pediatrics, University of Utah, Salt Lake City, UT; </p><div>Find articles by <a href="/pubmed/?term=Raetz%20EA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Elizabeth A. Raetz</a></div></div><div id="_co_idm140585497040992"><h3 class="no_margin">Stephen P. Hunger</h3><p><sup>16</sup>Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA; </p><div>Find articles by <a href="/pubmed/?term=Hunger%20SP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Stephen P. Hunger</a></div></div><div id="_co_idm140585497039008"><h3 class="no_margin">Paul Scheet</h3><p><sup>17</sup>Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX; </p><div>Find articles by <a href="/pubmed/?term=Scheet%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Paul Scheet</a></div></div><div id="_co_idm140585492543600"><h3 class="no_margin">Sima Jeha</h3><p><sup>1</sup>Department of Oncology and </p><div>Find articles by <a href="/pubmed/?term=Jeha%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Sima Jeha</a></div></div><div id="_co_idm140585503656688"><h3 class="no_margin">Ching-Hon Pui</h3><p><sup>1</sup>Department of Oncology and </p><div>Find articles by <a href="/pubmed/?term=Pui%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Ching-Hon Pui</a></div></div><div id="_co_idm140585507785680"><h3 class="no_margin">William E. Evans</h3><p><sup>2</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Evans%20WE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">William E. Evans</a></div></div><div id="_co_idm140585500029424"><h3 class="no_margin">Meenakshi Devidas</h3><p><sup>18</sup>Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL; and </p><div>Find articles by <a href="/pubmed/?term=Devidas%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Meenakshi Devidas</a></div></div><div id="_co_idm140585500027440"><h3 class="no_margin">Leonard A. Mattano, Jr</h3><p><sup>19</sup>HARP Pharma Consulting, Mystic, CT</p><div>Find articles by <a href="/pubmed/?term=Mattano%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Leonard A. Mattano, Jr</a></div></div><div id="_co_idm140585498617776"><h3 class="no_margin">Mary V. Relling</h3><p><sup>2</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </p><div>Find articles by <a href="/pubmed/?term=Relling%20MV%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26265699">Mary V. Relling</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140585496908032_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140585496908032_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140585496908032_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140585496908032_ai" style="display:none"><div class="fm-affl" id="aff1" lang="en"><sup>1</sup>Department of Oncology and </div><div class="fm-affl" id="aff2" lang="en"><sup>2</sup>Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff3" lang="en"><sup>3</sup>Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN; </div><div class="fm-affl" id="aff4" lang="en"><sup>4</sup>Department of Radiological Sciences, St. Jude Children’s Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff5" lang="en"><sup>5</sup>Department of Radiology, University of Tennessee, Memphis, TN; </div><div class="fm-affl" id="aff6" lang="en"><sup>6</sup>Office of Research, </div><div class="fm-affl" id="aff7" lang="en"><sup>7</sup>Department of Biomedical Informatics, </div><div class="fm-affl" id="aff8" lang="en"><sup>8</sup>Department of Pharmacology, and </div><div class="fm-affl" id="aff9" lang="en"><sup>9</sup>Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; </div><div class="fm-affl" id="aff10" lang="en"><sup>10</sup>Department of Pediatrics, Maine Medical Center, Portland, ME; </div><div class="fm-affl" id="aff11" lang="en"><sup>11</sup>Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX; </div><div class="fm-affl" id="aff12" lang="en"><sup>12</sup>Department of Pediatrics, New York University Langone Medical Center, New York, NY; </div><div class="fm-affl" id="aff13" lang="en"><sup>13</sup>Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN; </div><div class="fm-affl" id="aff14" lang="en"><sup>14</sup>Department of Pediatrics, University of California School of Medicine, San Francisco, CA; </div><div class="fm-affl" id="aff15" lang="en"><sup>15</sup>Department of Pediatrics, University of Utah, Salt Lake City, UT; </div><div class="fm-affl" id="aff16" lang="en"><sup>16</sup>Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA; </div><div class="fm-affl" id="aff17" lang="en"><sup>17</sup>Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX; </div><div class="fm-affl" id="aff18" lang="en"><sup>18</sup>Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL; and </div><div class="fm-affl" id="aff19" lang="en"><sup>19</sup>HARP Pharma Consulting, Mystic, CT</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup>Corresponding author.</div><div id="fn1"><sup>*</sup>S.E.K. and W.Y. contributed equally to this study.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140585496908032_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2015 May 6; Accepted 2015 Jul 29.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140585496908032_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2015 by The American Society of Hematology</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>See "<a href="/pubmed/26450951" class="int-reflink">ALL and osteonecrosis.</a>" in volume 126 on&nbsp;page&nbsp;1734.</div><div style="border-top: 1px solid rgb(102, 102, 153); margin: 5px 10% 3px;"></div><div>This article has been <a href="/pmc/articles/PMC4600016/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140585499490224" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140585499490224title">Key Points</h2><!--article-meta--><div><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
max-label-size=0
--><li><p id="__p4">Comprehensive study of glucocorticoid-induced osteonecrosis identifies glutamate receptor gene variants as risk factors.</p></li></ul><p></p></div></div><div id="idm140585499893792" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140585499893792title">Abstract</h2><!--article-meta--><div><p id="__p5" class="p p-first-last">Glucocorticoids are important therapy for acute lymphoblastic leukemia (ALL) and their major adverse effect is osteonecrosis. Our goal was to identify genetic and nongenetic risk factors for osteonecrosis. We performed a genome-wide association study of single nucleotide polymorphisms (SNPs) in a discovery cohort comprising 2285 children with ALL, treated on the Children’s Oncology Group AALL0232 protocol (<a id="__tag_562264415" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00075725" ref="reftype=extlink-clinical-trial&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00075725","term_id":"NCT00075725"}}</span>NCT00075725</a>), adjusting for covariates. The minor allele at SNP rs10989692 (near the glutamate receptor <em>GRIN3A</em> locus) was associated with osteonecrosis (hazard ratio = 2.03; <em>P</em> = 3.59 × 10<sup>−7</sup>). The association was supported by 2 replication cohorts, including 361 children with ALL on St. Jude’s Total XV protocol (<a id="__tag_562264414" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00137111" ref="reftype=extlink-clinical-trial&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00137111","term_id":"NCT00137111"}}</span>NCT00137111</a>) and 309 non-ALL patients from Vanderbilt University’s BioVU repository treated with glucocorticoids (odds ratio [OR] = 1.87 and 2.26; <em>P</em> = .063 and .0074, respectively). In a meta-analysis, rs10989692 was also highest ranked (<em>P</em> = 2.68 × 10<sup>−8</sup>), and the glutamate pathway was the top ranked pathway (<em>P</em> = 9.8 × 10<sup>−4</sup>). Osteonecrosis-associated glutamate receptor variants were also associated with other vascular phenotypes including cerebral ischemia (OR = 1.64; <em>P</em> = 2.5 × 10<sup>−3</sup>), and arterial embolism and thrombosis (OR = 1.88; <em>P</em> = 4.2 × 10<sup>−3</sup>). In conclusion, osteonecrosis was associated with inherited variations near glutamate receptor genes. Further understanding this association may allow interventions to decrease osteonecrosis. These trials are registered at <a href="http://www.clinicaltrials.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">www.clinicaltrials.gov</a> as #<a id="__tag_562264416" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00075725" ref="reftype=extlink-clinical-trial&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00075725","term_id":"NCT00075725"}}</span>NCT00075725</a> and #<a id="__tag_562264417" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00137111" ref="reftype=extlink-clinical-trial&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00137111","term_id":"NCT00137111"}}</span>NCT00137111</a>.</p></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Introduction</h2><p id="__p6" class="p p-first">Cure rates for childhood acute lymphoblastic leukemia (ALL) have approached 90% with therapeutic advances over the last several decades.<sup><a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775640">1</a><a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775637"></a><a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775626"></a><a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775623"></a><a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775630"></a>-<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775654">6</a></sup> Intensification of therapy with glucocorticoids has played a crucial role in achieving these outcomes. However, one of the most common therapy-related and dose-limiting toxicities of therapy in children with ALL is glucocorticoid-induced osteonecrosis, particularly in those older than 10 years of age. The majority of symptomatic cases of osteonecrosis occur within the first 2 years of treatment,<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775603">7</a>,<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775608">8</a></sup> often precipitating early withdrawal of glucocorticoids from therapy for ALL.</p><p id="__p7">The incidence of glucocorticoid-induced osteonecrosis varies widely.<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775619">7</a>,<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775642">9</a></sup> Age remains the most significant risk factor, with symptomatic osteonecrosis (defined as grades 2-4) occurring in 10% to 30% of children older than 10 years of age.<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775650">7</a>,<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775620">8</a>,<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775652">10</a><a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775641"></a>-<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775628">12</a></sup> Glucocorticoid-induced osteonecrosis also complicates treatment of nonmalignant conditions such as solid organ transplant and arthritis.<sup><a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775657">13</a><a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775599"></a>-<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775609">15</a></sup> Osteonecrosis can result in debilitation and adversely affect quality of life, often requiring surgical intervention.</p><p id="__p8" class="p p-last">In this study, we conducted the largest genome-wide association study (GWAS) to date of glucocorticoid-induced osteonecrosis, with replication cohorts including not only children treated for ALL<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775611">7</a></sup> but also adults and children treated with glucocorticoids for other medical conditions. Our goal was to identify germline genetic variants that predispose to glucocorticoid-induced osteonecrosis.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title">Methods</h2><div id="__sec3" class="sec sec-first"><h3 id="__sec3title">Subjects</h3><p id="__p9" class="p p-first">The discovery cohort included children with newly diagnosed ALL with germline DNA available who were treated on the Children’s Oncology Group (COG) AALL0232 protocol (<a id="__tag_562264418" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00075725" ref="reftype=extlink-clinical-trial&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00075725","term_id":"NCT00075725"}}</span>NCT00075725</a>) for high-risk B-precursor ALL (n = 2285) (<a href="/pmc/articles/PMC4600016/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>; see supplemental Figure 1 and supplemental Table 1 on the <em>Blood</em> Web site). Validation cohorts included children with newly diagnosed ALL treated on the St. Jude (SJ) Total XV protocol (<a id="__tag_562264419" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00137111" ref="reftype=extlink-clinical-trial&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00137111","term_id":"NCT00137111"}}</span>NCT00137111</a>) (n = 361)<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775597">7</a></sup> (supplemental Figure 1 and supplemental Table 2), and a separate cohort comprising children and adults treated with corticosteroids in the Vanderbilt University Medical Center Biorepository BioVU database<sup><a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775644">16</a></sup> (n = 309) (<a href="/pmc/articles/PMC4600016/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>; supplemental Figure 1 and supplemental Table 3). Patients included in the genetic association analyses represented 80% (n = 2285 of 2868) of participants on the COG AALL0232 protocol, and 73% (n = 361 of 498) of patients on the SJ Total XV protocol (supplemental Figure 1).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p10">Patient characteristics by cohort</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140585497966544" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="1" colspan="1"></th><th colspan="3" rowspan="1" align="center">COG AALL0232</th><th colspan="3" rowspan="1" align="center">SJ Total XV</th><th colspan="3" rowspan="1" align="center">Vanderbilt BioVU</th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1" align="center">All (n = 2285)</th><th rowspan="1" colspan="1" align="center">Cases (n = 250)</th><th rowspan="1" colspan="1" align="center">Controls (n = 2035)</th><th rowspan="1" colspan="1" align="center">All (n = 361)</th><th rowspan="1" colspan="1" align="center">Cases (n = 68)</th><th rowspan="1" colspan="1" align="center">Controls (n = 293)</th><th rowspan="1" colspan="1" align="center">All (n = 309)</th><th rowspan="1" colspan="1" align="center">Cases (n = 82)</th><th rowspan="1" colspan="1" align="center">Controls (n = 227)</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"><strong>Ancestry classification</strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"> White</td><td rowspan="1" colspan="1" align="center">1275</td><td rowspan="1" colspan="1" align="center">164 (12.9%)</td><td rowspan="1" colspan="1" align="center">1111 (87.1%)</td><td rowspan="1" colspan="1" align="center">260</td><td rowspan="1" colspan="1" align="center">53 (20.4%)</td><td rowspan="1" colspan="1" align="center">207 (79.6%)</td><td rowspan="1" colspan="1" align="center">216</td><td rowspan="1" colspan="1" align="center">57 (26.4%)</td><td rowspan="1" colspan="1" align="center">159 (73.6%)</td></tr><tr><td rowspan="1" colspan="1"> Black</td><td rowspan="1" colspan="1" align="center">139</td><td rowspan="1" colspan="1" align="center">4 (2.9%)</td><td rowspan="1" colspan="1" align="center">135 (97.1%)</td><td rowspan="1" colspan="1" align="center">55</td><td rowspan="1" colspan="1" align="center">6 (10.9%)</td><td rowspan="1" colspan="1" align="center">49 (89.0%)</td><td rowspan="1" colspan="1" align="center">54</td><td rowspan="1" colspan="1" align="center">15 (27.8%)</td><td rowspan="1" colspan="1" align="center">39 (72.2%)</td></tr><tr><td rowspan="1" colspan="1"> Hispanic</td><td rowspan="1" colspan="1" align="center">601</td><td rowspan="1" colspan="1" align="center">58 (9.7%)</td><td rowspan="1" colspan="1" align="center">543 (90.3%)</td><td rowspan="1" colspan="1" align="center">25</td><td rowspan="1" colspan="1" align="center">6 (24%)</td><td rowspan="1" colspan="1" align="center">19 (75%)</td><td rowspan="1" colspan="1" align="center">14</td><td rowspan="1" colspan="1" align="center">4 (28.6%)</td><td rowspan="1" colspan="1" align="center">10 (71.4%)</td></tr><tr><td rowspan="1" colspan="1"> Asian</td><td rowspan="1" colspan="1" align="center">48</td><td rowspan="1" colspan="1" align="center">5 (10.4%)</td><td rowspan="1" colspan="1" align="center">43 (89.6%)</td><td rowspan="1" colspan="1" align="center">4</td><td rowspan="1" colspan="1" align="center">0 (0%)</td><td rowspan="1" colspan="1" align="center">4 (100%)</td><td rowspan="1" colspan="1" align="center">2</td><td rowspan="1" colspan="1" align="center">1 (50.0%)</td><td rowspan="1" colspan="1" align="center">1 (50.0%)</td></tr><tr><td rowspan="1" colspan="1"> Other</td><td rowspan="1" colspan="1" align="center">222</td><td rowspan="1" colspan="1" align="center">19 (8.6%)</td><td rowspan="1" colspan="1" align="center">203 (91.4%)</td><td rowspan="1" colspan="1" align="center">17</td><td rowspan="1" colspan="1" align="center">3 (17.6%)</td><td rowspan="1" colspan="1" align="center">14 (82.4%)</td><td rowspan="1" colspan="1" align="center">23</td><td rowspan="1" colspan="1" align="center">5 (21.7%)</td><td rowspan="1" colspan="1" align="center">18 (78.3%)</td></tr><tr><td rowspan="1" colspan="1"><strong>Gender</strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"> Male</td><td rowspan="1" colspan="1" align="center">1244</td><td rowspan="1" colspan="1" align="center">120 (9.6%)</td><td rowspan="1" colspan="1" align="center">1124 (90.4%))</td><td rowspan="1" colspan="1" align="center">197</td><td rowspan="1" colspan="1" align="center">37 (18.8%)</td><td rowspan="1" colspan="1" align="center">160 (81.2%)</td><td rowspan="1" colspan="1" align="center">100</td><td rowspan="1" colspan="1" align="center">29 (29.0%)</td><td rowspan="1" colspan="1" align="center">71 (71.0%)</td></tr><tr><td rowspan="1" colspan="1"> Female</td><td rowspan="1" colspan="1" align="center">1041</td><td rowspan="1" colspan="1" align="center">130 (12.5%)</td><td rowspan="1" colspan="1" align="center">911 (87.5%)</td><td rowspan="1" colspan="1" align="center">164</td><td rowspan="1" colspan="1" align="center">31 (18.9%)</td><td rowspan="1" colspan="1" align="center">133 (81.1%)</td><td rowspan="1" colspan="1" align="center">209</td><td rowspan="1" colspan="1" align="center">53 (25.4%)</td><td rowspan="1" colspan="1" align="center">156 (74.6%)</td></tr><tr><td rowspan="1" colspan="1"><strong>Age (y, at diagnosis)</strong></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"> 1-10</td><td rowspan="1" colspan="1" align="center">817</td><td rowspan="1" colspan="1" align="center">20 (2.4%)</td><td rowspan="1" colspan="1" align="center">797 (97.6%)</td><td rowspan="1" colspan="1" align="center">270</td><td rowspan="1" colspan="1" align="center">28 (10.4%)</td><td rowspan="1" colspan="1" align="center">242 (89.6%)</td><td rowspan="1" colspan="1" align="center">13</td><td rowspan="1" colspan="1" align="center">2 (15.4%)</td><td rowspan="1" colspan="1" align="center">11 (84.6%)</td></tr><tr><td rowspan="1" colspan="1"> ≥10</td><td rowspan="1" colspan="1" align="center">1468</td><td rowspan="1" colspan="1" align="center">230 (15.7%)</td><td rowspan="1" colspan="1" align="center">1238 (84.3%)</td><td rowspan="1" colspan="1" align="center">91</td><td rowspan="1" colspan="1" align="center">40 (44.0%)</td><td rowspan="1" colspan="1" align="center">51 (56%)</td><td rowspan="1" colspan="1" align="center">296</td><td rowspan="1" colspan="1" align="center">80 (27.0%)</td><td rowspan="1" colspan="1" align="center">216 (73.0%)</td></tr></tbody></table></div><div id="largeobj_idm140585497966544" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4600016/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140585496829872"><p id="__p11" class="p p-first-last">Patient characteristics are listed by osteonecrosis cases and controls within each cohort. Ancestry was genomically determined as described in “Methods.”</p></div></div></div><p id="__p12">Informed consent was obtained from patients 18 years and older, and from parents or guardians for patients under the age of 18 in accordance with the Declaration of Helsinki. The COG AALL0232 protocol was approved by the National Cancer Institute and the Institutional Review Boards (IRBs) of participating institutions. The SJ Total XV trial was approved by the SJ IRB.</p><p id="__p13" class="p p-last">The second validation cohort for this study was derived from BioVU, Vanderbilt’s repository linking DNA from remnant blood samples to de-identified electronic medical record data.<sup><a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775638">17</a></sup> Due to de-identification, use of this resource qualifies as nonhuman subjects research. IRB exemption was required by the institution and was obtained prior to the study. Cases of glucocorticoid-induced osteonecrosis were identified using the de-identified electronic medical records in BioVU using keyword searches, International Classification of Disease, 9th edition codes, and exclusion criteria described in supplemental Materials. Controls were selected in a 3:1 (controls:cases) ratio, and matched on age, race, gender, and primary diagnoses. All cases and controls were manually reviewed to confirm inclusion/exclusion criteria (supplemental Figure 2).</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Detection of adverse events</h3><p id="__p14" class="p p-first-last">Osteonecrosis was graded using the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0 for SJ Total XV and version 4.0 for COG AALL0232, and categorized as absent (grade 0), asymptomatic (grade 1), moderate (grade 2), severe (grade 3), or disabling (grade 4). Patients with symptomatic grades 2-4 were considered to have osteonecrosis. For patients on AALL0232, patients with symptoms suggestive of osteonecrosis were evaluated by magnetic resonance imaging (MRI) to verify the diagnosis. In the SJ cohort, all patients were prospectively screened for osteonecrosis with serial MRI, regardless of symptoms. Details for case ascertainment in the Vanderbilt cohort are provided (supplemental Materials and methods).</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Genotyping</h3><p id="__p15" class="p p-first-last">Single nucleotide polymorphism (SNP) genotyping was performed on germline DNA from patients from the COG AALL0232 and SJ Total XV protocols using the Illumina Human Exome BeadChip v1.1 and Affymetrix GeneChip Human Mapping Array 6.0. The Illumina Exome Chip, Omni1-Quad, 1M-Duo, and Human660W-Quad BeadChip Arrays were used for the Vanderbilt BioVU cohort. For SNPs not interrogated on the arrays, imputation was performed using the 1000 Genomes Project (<a href="http://www.1000genomes.org/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.1000genomes.org/</a>) database as the reference genome, leveraging linkage disequilibrium (LD) within racial ethnic groups (Northern European ancestry, West African ancestry, and other) with MaCH-Admix software (University of North Carolina) for the COG AALL0232 and SJ Total XV cohorts, and IMPUTE2 (University of Oxford, United Kingdom) for the Vanderbilt cohort.<sup><a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775639">18</a><a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775643"></a>-<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775625">20</a></sup> For the imputation, reference groups for imputing SNPs in patients classified as white (see below) were as follows: the European individuals in 1000 Genomes, for patients classified as black were the 1000 Genomes Africans, and the remaining patients were all individuals in the 1000 Genomes database.</p></div><div id="__sec6" class="sec"><h3 id="__sec6title">Genetic ancestry race classification</h3><p id="__p16" class="p p-first-last">Genetic ancestry for each patient was determined using STRUCTURE (version 2.2.3).<sup><a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775602">21</a></sup> When ancestry was assessed as a categorical variable, individuals were classified as white, black, Hispanic, and Asian based on percentage-inferred genetic ancestry as follows: &gt;90% Northern European (CEU) were classified as white; &gt;70% West African (YRI) were classified as black; &gt;90% East Asian (CHB/JPT) were classified as Asian; those with Native American ancestry &gt;10% and greater than the percentage of West African ancestry were classified as Hispanic. Patients not falling into these groups were categorized as “Other.”</p></div><div id="__sec7" class="sec"><h3 id="__sec7title">Quality control</h3><p id="__p17" class="p p-first-last">Identical quality control measures were enforced for the discovery and validation cohorts. All SNPs with a call rate &lt;95% were excluded. SNPs with a minor allele frequency (MAF) &gt;1% but deviating from Hardy–Weinberg equilibrium within Europeans (<em>P</em> &lt; .0001) were also excluded. Otherwise, no MAF threshold was enforced.</p></div><div id="__sec8" class="sec sec-last"><h3 id="__sec8title">Statistical analyses</h3><p id="__p18" class="p p-first">For the discovery GWAS, SNP genotypes were compared in 250 ALL osteonecrosis cases and 2035 controls enrolled on COG AALL0232. Adjusting for gender, age, percent ancestry as a continuous variable, and treatment (see supplemental Materials and methods for details on consideration of treatment variables), association of genotypes with ON was tested with a Cox proportional hazard model for time-dependent analyses and logistic regression for time-independent analyses. For the time-independent analyses, only patients with a follow-up time of 800 days or greater from the start of therapy on COG AALL0232 were included in the analysis. Results from analyses with imputed SNPs and each independent platform were merged and rank ordered by <em>P</em> value. Analyses were performed using R software (version 3.0; <a href="http://www.r-project.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.r-project.org</a>).</p><p id="__p19">We excluded rare/low frequency SNPs (MAF &lt;0.1) with a protective, negative correlation with osteonecrosis risk (odds ratio [OR] &lt;1).</p><p id="__p20">Time-independent analyses were performed using a logistic regression model in the 2 validation cohorts: 68 osteonecrosis cases and 293 controls from the SJ Total XV cohort as previously published,<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775655">7</a></sup> and 82 cases and 227 controls from the Vanderbilt BioVU cohort. Meta-analysis of the discovery and validation cohorts was performed using Stouffer’s Z-score method.<sup><a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775651">22</a></sup></p><p id="__p21">Pathway and network analyses were performed to identify biological networks enriched within the top ranked SNPs for each of the cohorts using QIAGEN Ingenuity Pathway Analysis (<a href="http://www.qiagen.com/ingenuity" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.qiagen.com/ingenuity</a>). Top SNPs were selected with meta-analysis <em>P</em> value cutoffs &lt; .0001 or &lt; .001, and genes closest to SNPs based on chromosomal location were used for the pathway analyses.</p><p id="__p22" class="p p-last">The phenome-wide association studies (PheWAS) analysis was performed as described<sup><a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775622">23</a>,<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775624">24</a></sup> (supplemental Materials and methods) for the 137 SNPs within the glutamate receptor signaling pathway genes. We tested for their associations with 1358 phenotypes using the extant BioVU genotype data linked to electronic health records for over 10 000 individuals.</p></div></div><div id="__sec9" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec9title">Results</h2><div id="__sec10" class="sec sec-first"><h3 id="__sec10title">Covariates included in the GWAS</h3><p id="__p23" class="p p-first">The overall frequency of symptomatic grades 2-4 osteonecrosis in patients included in the entire COG AALL0232 cohort (all ages) was 10.9%. For the discovery COG AALL0232 cohort, a Cox proportional hazard model with nongenetic and clinical factors was used to identify covariates to include in the GWAS. Multivariate analysis revealed age ≥10 years (hazard ratio [HR] = 11.1; 95% CI, 6.7-18.1; <em>P</em> = 1.57 × 10<sup>−21</sup>), and female gender (HR = 1.39; 95% CI, 1.08-1.78; <em>P</em> = 9.82 × 10<sup>−3</sup>) (supplemental Table 1) to be associated with a higher risk of osteonecrosis. African genetic ancestry was associated with a decreased risk of osteonecrosis compared with individuals of European genetic ancestry (HR = 0.19; 95% CI, 0.07-0.51; <em>P</em> = 1.02 × 10<sup>−3</sup>). Treatment variables A and B (supplemental Materials and methods and supplemental Table 4) were also included as covariates in the GWAS.</p><p id="__p24" class="p p-last">As reported previously,<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775616">7</a></sup> the cumulative incidence of symptomatic osteonecrosis grades 2-4 in the SJ Total XV cohort was 17.6%, with older age (<em>P</em> = 7.81 × 10<sup>−7</sup>) and more intensive therapy (<em>P</em> = 9.48 × 10<sup>−3</sup>) as significant covariates (supplemental Table 2).<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775596">7</a></sup></p></div><div id="__sec11" class="sec"><h3 id="__sec11title">GWAS</h3><p id="__p25" class="p p-first">In the discovery GWAS in the COG AALL0232 cohort, adjusting for gender, age, ancestry, and treatment, a variant at 9q31.1 (rs10989692, <em>P</em> = 3.59 × 10<sup>−7</sup>), ∼170kb 5′ of the <em>GRIN3A</em> locus (glutamate [NMDA] receptor subunit 3A), had the strongest association with osteonecrosis risk in both a time-dependent and time-independent analysis <strong>(</strong>supplemental Tables 5 and 6; supplemental Figure 3<strong>)</strong>. Patients with an additional A allele at rs10989692 had a higher risk of osteonecrosis (HR = 2.03; 95% CI, 1.55-2.66) (<a href="/pmc/articles/PMC4600016/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1A</span></a>), with 73 of 250 cases carrying a risk allele (69 heterozygous and 4 homozygous). The correlation between rs10989692 genotypes and osteonecrosis was stronger in patients with &gt;90% European ancestry (n = 1268; HR = 2.22; 95% CI, 1.64-2.99) (<a href="/pmc/articles/PMC4600016/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>), risk allele frequency (RAF) in patients with and without osteonecrosis (0.173 vs 0.089; <em>P</em> = 1.7 × 10<sup>−6</sup>) than in patients of non-European ancestry (n = 1017; HR = 1.63; 95% CI, 0.98-2.63; <em>P</em> = .057) (<a href="/pmc/articles/PMC4600016/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>; supplemental Figure 4). SNP rs10989692 was further validated in the Vanderbilt cohort (OR = 2.26; <em>P</em> = .0074), again with a stronger association in whites (n = 216; OR = 2.68; <em>P</em> = .012; RAF: 0.132 in cases vs 0.06 in controls) than in those with non-European ancestries (n = 93; OR = 1.72; <em>P</em> = .26). The effect of rs10989692 in the SJ cohort was marginal when all patients were included (OR = 1.87; <em>P</em> = .063), but reached statistical significance when only patients with &gt;90% European ancestry were considered (n = 260; OR = 2.29; <em>P</em> = .028; RAF: 0.123 in cases vs 0.086 in controls). The RAF was very similar in both the discovery and replication cohorts (0.106, 0.116, and 0.130 for COG, SJ, and Vanderbilt cohorts, respectively). An additional SNP (rs28584318) in high LD with rs10989692 (<em>r</em><sup>2</sup> = 1 and 0.83 in HapMap CEU and African populations, respectively) was also associated with osteonecrosis (<em>P</em> = 4.86 × 10<sup>−7</sup>; <em>P</em> = .07; <em>P</em> = .0073 in AALL0232, SJ, and Vanderbilt cohorts, respectively).<sup><a href="#B25" rid="B25" class=" bibr popnode">25</a></sup> We evaluated the effect of the rs10989692 SNP across different ancestral groups by analysis of variance test of the interaction term of the genotype and genetic ancestry in AALL0232. The <em>P</em> value for the interaction term, <em>P</em> = .075, suggests that there may be a difference in the effect size of this polymorphism across ancestral groups. When restricting the analysis to patients &gt;10 years, the risk associated with rs10989692 was maintained in AALL0232 (n = 1468; HR = 2.07; 95% CI, 1.59-2.70; <em>P</em> = 1.44 × 10<sup>−6</sup>; RAF 0.152 in cases vs 0.0905 in controls) with a similar trend in the SJ cohort that did not reach statistical significance (n = 91; HR = 1.67; 95% CI, 0.55-5.10; <em>P</em> = .37; RAF 0.10 in cases vs 0.077 in controls) (supplemental Tables 7 and 8; supplemental Figure 3C), and interaction analyses between genotype and age did not show a significant interaction between <em>GRIN3A</em> rs10989692 genotype and age (<em>P</em> = .86 and <em>P</em> = .89) in the AALL0232 and TOTALXV cohorts, respectively.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC4600016/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140585502974912" class="figure"><a href="/pmc/articles/PMC4600016/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4600016_1770f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 1770f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4600016/bin/1770f1.jpg"></a></div><div id="largeobj_idm140585502974912" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4600016/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC4600016/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p26"><strong>Cumulative incidence of osteonecrosis by rs10989692 genotype in COG AALL0232.</strong> The cumulative incidence of osteonecrosis was higher in those carrying the A allele at rs10989692 (5′ of <em>GRIN3A</em>) in COG AALL0232 (A) in all ancestry groups combined, adjusting for ancestry (n = 2285), and (B) among whites only (n = 1268).</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC4600016/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140585499382672" class="figure"><a href="/pmc/articles/PMC4600016/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4600016_1770f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 1770f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4600016/bin/1770f2.jpg"></a></div><div id="largeobj_idm140585499382672" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4600016/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC4600016/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p27"><strong>Effect size for rs10989692 and rs2154490 genotypes by cohort.</strong> Effect sizes are computed as the HR for COG AALL0232 based on time-dependent analysis, and OR for SJ Total XV and Vanderbilt BioVU based on time-independent analyses. Effect sizes for rs10989692 and rs2154490 are shown after adjusting for age, gender, treatment arm, and ancestry in COG and SJ, and after adjusting for age, gender, and ancestry in Vanderbilt BioVU. Asterisk (*) denotes effect size.</p></div></div></div></div><div id="__sec12" class="sec"><h3 id="__sec12title">Meta-analysis</h3><p id="__p28" class="p p-first">Meta-analysis was performed by combining GWAS results from both the discovery cohort and the 2 validation cohorts. The 9q31.1 locus (near <em>GRIN3A</em>) was the highest ranked region, including multiple SNPs in LD with rs10989692 (<em>P</em> = 2.68 × 10<sup>−8</sup>) (<a href="/pmc/articles/PMC4600016/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>; <a href="/pmc/articles/PMC4600016/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>). After the 9q31.1 locus, the next highest ranked variant was an intronic SNP rs2154490 in glutamate receptor, ionotropic, kainate (<em>GRIK1</em>) on chromosome 21 (<em>P</em> = 1.28 × 10<sup>−6</sup>) (<a href="/pmc/articles/PMC4600016/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>; <a href="/pmc/articles/PMC4600016/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>). The additional minor A allele at rs2154490 conferred a higher risk of osteonecrosis in all 3 cohorts: COG AALL0232 (HR = 1.29; <em>P</em> = .016), SJ Total XV (OR = 1.86; <em>P</em> = .0078), and Vanderbilt (OR = 2.13; <em>P</em> = 9.1 × 10<sup>−4</sup>) <strong>(</strong>supplemental Figure 5<strong>)</strong>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p29">Top SNPs from meta-analysis across COG AALL0232, SJ Total XV, and Vanderbilt BioVU cohorts</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140585498991088" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th rowspan="1" colspan="1" align="center"></th><th colspan="3" rowspan="1" align="center">COG AALL0232</th><th colspan="3" rowspan="1" align="center">SJ Total XV</th><th colspan="3" rowspan="1" align="center">Vanderbilt BioVU</th></tr><tr><th rowspan="1" colspan="1">SNP ID<sup>*</sup></th><th rowspan="1" colspan="1" align="center">Chr</th><th rowspan="1" colspan="1" align="center">Position (HG19)<sup>†</sup></th><th rowspan="1" colspan="1" align="center">Alleles<sup>‡</sup></th><th rowspan="1" colspan="1" align="center">Gene<sup>§</sup></th><th rowspan="1" colspan="1" align="center">SNP function</th><th rowspan="1" colspan="1" align="center">Meta <em>P</em></th><th rowspan="1" colspan="1" align="center">RAF</th><th rowspan="1" colspan="1" align="center"><em>P</em></th><th rowspan="1" colspan="1" align="center">HR (95%CI)</th><th rowspan="1" colspan="1" align="center">RAF</th><th rowspan="1" colspan="1" align="center"><em>P</em></th><th rowspan="1" colspan="1" align="center">OR (95%CI)</th><th rowspan="1" colspan="1" align="center">RAF</th><th rowspan="1" colspan="1" align="center"><em>P</em></th><th rowspan="1" colspan="1" align="center">OR (95%CI)</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">rs10989692</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="center">104674555</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">5′ of GRIN3A</td><td rowspan="1" colspan="1" align="center">Intergenic</td><td rowspan="1" colspan="1" align="center">2.68 × 10<sup>−8</sup></td><td rowspan="1" colspan="1" align="center">0.106</td><td rowspan="1" colspan="1" align="center">3.59 × 10<sup>−7</sup></td><td rowspan="1" colspan="1" align="center">2.03 (1.55 - 2.66)</td><td rowspan="1" colspan="1" align="center">0.116</td><td rowspan="1" colspan="1" align="center">0.063</td><td rowspan="1" colspan="1" align="center">1.87 (0.97 - 3.60)</td><td rowspan="1" colspan="1" align="center">0.130</td><td rowspan="1" colspan="1" align="center">0.0074</td><td rowspan="1" colspan="1" align="center">2.26 (1.24 - 4.11)</td></tr><tr><td rowspan="1" colspan="1">rs2154490</td><td rowspan="1" colspan="1" align="center">21</td><td rowspan="1" colspan="1" align="center">30915962</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">GRIK1</td><td rowspan="1" colspan="1" align="center">Intronic</td><td rowspan="1" colspan="1" align="center">1.28 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.222</td><td rowspan="1" colspan="1" align="center">0.016</td><td rowspan="1" colspan="1" align="center">1.29 (1.05 - 1.56)</td><td rowspan="1" colspan="1" align="center">0.233</td><td rowspan="1" colspan="1" align="center">0.0078</td><td rowspan="1" colspan="1" align="center">1.86 (1.18 - 2.94)</td><td rowspan="1" colspan="1" align="center">0.240</td><td rowspan="1" colspan="1" align="center">9.1 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">2.13 (1.36 - 3.32)</td></tr><tr><td rowspan="1" colspan="1">rs72733993</td><td rowspan="1" colspan="1" align="center">5</td><td rowspan="1" colspan="1" align="center">18408908</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">Intergenic</td><td rowspan="1" colspan="1" align="center">2.67 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.156</td><td rowspan="1" colspan="1" align="center">0.043</td><td rowspan="1" colspan="1" align="center">1.29 (1.01 - 1.64)</td><td rowspan="1" colspan="1" align="center">0.102</td><td rowspan="1" colspan="1" align="center">0.0051</td><td rowspan="1" colspan="1" align="center">2.62 (1.34 - 5.15)</td><td rowspan="1" colspan="1" align="center">0.119</td><td rowspan="1" colspan="1" align="center">9.4 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">2.89 (1.54 - 5.42)</td></tr><tr><td rowspan="1" colspan="1">rs11144550</td><td rowspan="1" colspan="1" align="center">9</td><td rowspan="1" colspan="1" align="center">78261548</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">5′ of PCSK5</td><td rowspan="1" colspan="1" align="center">Intergenic</td><td rowspan="1" colspan="1" align="center">3.08 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.137</td><td rowspan="1" colspan="1" align="center">2.37 × 10<sup>−5</sup></td><td rowspan="1" colspan="1" align="center">1.70 (1.33 - 2.17)</td><td rowspan="1" colspan="1" align="center">0.136</td><td rowspan="1" colspan="1" align="center">0.0629</td><td rowspan="1" colspan="1" align="center">1.71 (0.97 - 3.01)</td><td rowspan="1" colspan="1" align="center">0.078</td><td rowspan="1" colspan="1" align="center">0.046</td><td rowspan="1" colspan="1" align="center">2.04 (1.01 - 4.11)</td></tr><tr><td rowspan="1" colspan="1">rs1536407</td><td rowspan="1" colspan="1" align="center">13</td><td rowspan="1" colspan="1" align="center">75095567</td><td rowspan="1" colspan="1" align="center">C/A</td><td rowspan="1" colspan="1" align="center">5′ of KLF12</td><td rowspan="1" colspan="1" align="center">Intergenic</td><td rowspan="1" colspan="1" align="center">4.43 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.646</td><td rowspan="1" colspan="1" align="center">0.0064</td><td rowspan="1" colspan="1" align="center">1.32 (1.08 -1.61)</td><td rowspan="1" colspan="1" align="center">0.638</td><td rowspan="1" colspan="1" align="center">0.002</td><td rowspan="1" colspan="1" align="center">2.13 (1.32 - 3.45)</td><td rowspan="1" colspan="1" align="center">0.660</td><td rowspan="1" colspan="1" align="center">0.034</td><td rowspan="1" colspan="1" align="center">1.59 (1.03 - 2.44)</td></tr><tr><td rowspan="1" colspan="1">rs4789693</td><td rowspan="1" colspan="1" align="center">17</td><td rowspan="1" colspan="1" align="center">80421870</td><td rowspan="1" colspan="1" align="center">A/C</td><td rowspan="1" colspan="1" align="center">NARF</td><td rowspan="1" colspan="1" align="center">intronic</td><td rowspan="1" colspan="1" align="center">5.73 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.274</td><td rowspan="1" colspan="1" align="center">0.030</td><td rowspan="1" colspan="1" align="center">1.25 (1.02 - 1.54)</td><td rowspan="1" colspan="1" align="center">0.245</td><td rowspan="1" colspan="1" align="center">0.013</td><td rowspan="1" colspan="1" align="center">1.86 (1.14 - 3.05)</td><td rowspan="1" colspan="1" align="center">0.264</td><td rowspan="1" colspan="1" align="center">0.0014</td><td rowspan="1" colspan="1" align="center">1.95 (1.29 - 2.93)</td></tr><tr><td rowspan="1" colspan="1">rs6797178</td><td rowspan="1" colspan="1" align="center">3</td><td rowspan="1" colspan="1" align="center">137253713</td><td rowspan="1" colspan="1" align="center">G/A</td><td rowspan="1" colspan="1" align="center">5′ of SOX14</td><td rowspan="1" colspan="1" align="center">Intergenic</td><td rowspan="1" colspan="1" align="center">5.74 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.390</td><td rowspan="1" colspan="1" align="center">0.025</td><td rowspan="1" colspan="1" align="center">1.24 (1.03 - 1.49)</td><td rowspan="1" colspan="1" align="center">0.413</td><td rowspan="1" colspan="1" align="center">0.0023</td><td rowspan="1" colspan="1" align="center">2.00 (1.28 - 3.11)</td><td rowspan="1" colspan="1" align="center">0.430</td><td rowspan="1" colspan="1" align="center">0.01</td><td rowspan="1" colspan="1" align="center">1.63 (1.12 - 2.37)</td></tr><tr><td rowspan="1" colspan="1">rs10849004</td><td rowspan="1" colspan="1" align="center">12</td><td rowspan="1" colspan="1" align="center">4292862</td><td rowspan="1" colspan="1" align="center">T/C</td><td rowspan="1" colspan="1" align="center">5′ of CCND2</td><td rowspan="1" colspan="1" align="center">Intergenic</td><td rowspan="1" colspan="1" align="center">5.75 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.819</td><td rowspan="1" colspan="1" align="center">0.0029</td><td rowspan="1" colspan="1" align="center">1.47 (1.14 - 1.89)</td><td rowspan="1" colspan="1" align="center">0.817</td><td rowspan="1" colspan="1" align="center">3.1 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">3.45 (1.75 -6.67)</td><td rowspan="1" colspan="1" align="center">0.791</td><td rowspan="1" colspan="1" align="center">0.20</td><td rowspan="1" colspan="1" align="center">1.39 (0.83 - 2.27)</td></tr><tr><td rowspan="1" colspan="1">rs11594258</td><td rowspan="1" colspan="1" align="center">10</td><td rowspan="1" colspan="1" align="center">79218030</td><td rowspan="1" colspan="1" align="center">T/A</td><td rowspan="1" colspan="1" align="center">KCNMA1</td><td rowspan="1" colspan="1" align="center">Intronic</td><td rowspan="1" colspan="1" align="center">8.61 × 10<sup>−6</sup></td><td rowspan="1" colspan="1" align="center">0.822</td><td rowspan="1" colspan="1" align="center">2.8 × 10<sup>−4</sup></td><td rowspan="1" colspan="1" align="center">1.59 (1.23 - 2.04)</td><td rowspan="1" colspan="1" align="center">0.867</td><td rowspan="1" colspan="1" align="center">0.2</td><td rowspan="1" colspan="1" align="center">1.52 (0.80 - 2.86)</td><td rowspan="1" colspan="1" align="center">0.842</td><td rowspan="1" colspan="1" align="center">0.0052</td><td rowspan="1" colspan="1" align="center">2.44 (1.30 - 4.55)</td></tr></tbody></table></div><div id="largeobj_idm140585498991088" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4600016/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm140585503652144"><p id="__p30" class="p p-first-last">Listed are 9 loci with meta <em>P</em> &lt;1 × 10<sup>−5</sup>. Within each locus, only the SNP with the lowest <em>P</em> value is shown. RAF in each of the 3 cohorts; HR from time-dependent analysis in COG AALL0232 cohort; OR from time independent analysis in SJ Total XV and Vanderbilt BioVU cohorts.</p></div><div id="idm140585497517824"><p id="__p31" class="p p-first-last">CI, confidence interval.</p></div><div id="TF2-1"><sup>*</sup>Rs numbers according to the National Center for Biotechnology Information dbSNP release 139.</div><div id="TF2-2"><sup>†</sup>Physical location of SNPs based on human genome assembly (hg19).</div><div id="TF2-3"><sup>‡</sup>The second allele listed is the risk allele.</div><div id="TF2-4"><sup>§</sup>Refseq gene located closest to the SNP within a distance of 1M base pairs.</div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC4600016/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140585500061216" class="figure"><a href="/pmc/articles/PMC4600016/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4600016_1770f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 1770f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4600016/bin/1770f3.jpg"></a></div><div id="largeobj_idm140585500061216" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4600016/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC4600016/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p36"><strong>Manhattan plot of results from meta-analysis.</strong> Inverse of log <em>P</em> value for SNP associations with osteonecrosis risk from meta-analysis of COG AALL0232 (n = 2285), SJ Total XV (n = 361), and Vanderbilt BioVU (n = 309), adjusting for age, gender, treatment, and ancestry group in COG AALL0232 and SJ, and adjusting for age, gender, and ancestry groups in Vanderbilt BioVU. SNPs near <em>GRIN3A</em> and within <em>GRIK1</em> had the strongest association.</p></div></div></div><p id="__p37" class="p p-last">The top nonsense SNP from the meta-analysis <strong>(</strong>supplemental Table 9<strong>)</strong> was within pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 (or <em>PLEKHH1</em>) (<em>P</em> = .0023), involved in phosphate binding and implicated in liver lipid homeostasis.<sup><a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775635">26</a></sup> Another nonsense SNP (<em>P</em> = .0056) was within <em>STEAP4,</em> a ferrireductase involved in osteoclastogenesis<sup><a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775614">27</a></sup> and adipocyte development.<sup><a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775629">28</a></sup> Additional missense loci of interest from the meta-analysis include those in <em>ZFHX3</em>, a gene involved in atrial fibrillation and Kawasaki disease<sup><a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775632">29</a></sup> (<em>P</em> = 1.46 × 10<sup>−6</sup>), and loci in <em>COL22A1</em> (collagen, type XXII, α 1; <em>P</em> = .0003), involved in maintaining integrity of tissue junctions.</p></div><div id="__sec13" class="sec sec-last"><h3 id="__sec13title">Pathway analysis and PheWAS</h3><p id="__p38" class="p p-first">Based on the meta-analysis, there were 197 SNPs with <em>P</em> values &lt; .0001, which were annotated to 64 genes <strong>(</strong>supplemental Table 10<strong>)</strong>. Ingenuity Pathway Analysis using these 64 genes (supplemental Table 11) showed that the glutamate receptor-signaling pathway, including 3 genes <em>GRIN3A</em>, <em>GRIK1</em>, and <em>GRM7,</em> was the top canonical pathway (<em>P</em> = 4.8 × 10<sup>−4</sup>). Using a <em>P</em> value cutoff of .001, there were 433 genes, and the glutamate receptor-signaling pathway remained the top pathway, with additional genes in the pathway including <em>GRM3</em>, <em>GRIK4</em>, and <em>GRIA1</em> (<em>P</em> = 9.8 × 10<sup>−4</sup>) (supplemental Table 11).</p><p id="__p39" class="p p-last">All SNPs with <em>P</em> value &lt; .05 in or near genes within the glutamate pathway found to be significant in at least 1 of 3 cohorts were selected for analysis in a PheWAS (supplemental Materials) of the Vanderbilt University Medical Center BioVU database to explore whether these same osteonecrosis variants were associated with any of 1358 other phenotypes in the BioVU repository <strong>(</strong>supplemental Table 12). None of these associations achieved a Bonferroni significance threshold of 3.7 × 10<sup>−5</sup>. However, among the top 5 phenotypes associated with SNPs in <em>GRIN3A</em> were diseases of the respiratory tract (OR = 3.02; <em>P</em> = 3.1 × 10<sup>−4</sup>) and the long-term use of antithrombotics within the circulatory system (OR = 2.13; <em>P</em> = 4.7 × 10<sup>−4</sup>) <strong>(</strong>supplemental Table 13<strong>)</strong>. Other phenotypes included cerebral ischemia (OR = 1.64; <em>P</em> = 2.5 × 10<sup>−3</sup>), and arterial embolism and thrombosis (OR = 1.88; <em>P</em> = 4.2 × 10<sup>−3</sup>).</p></div></div><div id="__sec14" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec14title">Discussion</h2><p id="__p40" class="p p-first">The development of osteonecrosis can result in serious debilitation and requires surgical intervention in many cases. For example, in the Children’s Cancer Group 1961 study, 143 patients (of 2056 enrolled) developed symptomatic osteonecrosis at 377 confirmed sites leading to 139 surgeries.<sup><a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775604">8</a></sup> Identification of risk factors for the development of osteonecrosis in patients undergoing therapy for ALL might facilitate tailoring therapy to minimize its risk.</p><p id="__p41">In this study, we performed a GWAS, which identified a locus at 9q31.1 near <em>GRIN3A</em> as associated with osteonecrosis in both the discovery and validation cohorts, and the second highest ranked variant was in a related gene, <em>GRIK1</em>. The same <em>GRIN3A</em> variant was associated in the meta-analysis of the discovery and validation cohorts (<em>P</em> = 2.68 × 10<sup>−8</sup>), and the glutamate receptor pathway was the top canonical pathway based on the meta-analysis of all 3 cohorts. These findings suggest the involvement of the glutamate pathway in the pathogenesis of osteonecrosis not only in childhood ALL, but in a heterogeneous cohort of children and adults who were treated with prolonged corticosteroids for other medical conditions.<sup><a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775618">30</a>,<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775647">31</a></sup> Interestingly, we previously reported that polymorphisms within a third glutamate receptor gene, <em>GRIA1</em>, were the top genomic variants associated with asparaginase allergy in a GWAS of children with ALL in the SJ cohort,<sup><a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775646">32</a></sup> a finding recently independently replicated.<sup><a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775605">33</a></sup> We have also reported that asparaginase allergy was associated with lower systemic exposure to asparaginase,<sup><a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775634">34</a></sup> which in turn was associated with a lower risk of osteonecrosis in the SJ cohort.<sup><a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775633">35</a></sup> This prompted us to evaluate asparaginase allergy in the COG AALL0232 discovery cohort (n = 1845 with follow-up &gt;800 days), and consistent with the SJ cohort, grades 2-4 asparaginase allergy was associated with the risk of osteonecrosis: 206 out of 1647 (12.5%) for those without asparaginase allergies had osteonecrosis compared with 12 out of 198 (6.7%) for those with asparaginase allergies (<em>P</em> = .0096).</p><p id="__p42">Concomitant asparaginase treatment is associated with higher plasma exposure to dexamethasone.<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775645">7</a>,<a href="#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775606">34</a></sup> Although it is possible that the glutamate receptor pathway association was via secondary effects on asparaginase, which affects risk of osteonecrosis in ALL patients,<sup><a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775598">35</a></sup> this does not explain the association of the glutamate pathway within the BioVU cohort, whose patients did not receive asparaginase, and thus also implicates a mechanism with a direct effect of glutamate receptors. Multiple mechanisms can lead to osteonecrosis, with contributions to risk from therapy and host-specific factors.</p><p id="__p43">Previously described biologic mechanisms by which glucocorticoids may induce osteonecrosis include thrombosis, hyperlipidemia-associated enlarged adipocytes in bone, arteriopathy, and direct toxicity to osteocytes.<sup><a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775653">36</a><a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775621"></a><a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775601"></a><a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775627"></a><a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775617"></a>-<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775656">41</a></sup> Prior candidate gene and genome-wide investigations have implicated polymorphisms involved in lipid homeostasis (<em>ACP1</em>), fibrinolysis (<em>SERPINE1</em>), antifolate pharmacodynamics (thymidylate synthetase), and glucocorticoid response (<em>VDR</em>).<sup><a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775649">7</a>,<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775636">10</a>,<a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775600">42</a>,<a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775607">43</a></sup> These variants did not replicate in the discovery cohort, possibly due to differences in therapy and methods of case/control ascertainment. Differences in therapy and in frequency of performing MRIs may also explain the different rates of osteonecrosis seen in the AALL0232 and SJ Total XV protocols. Importantly, the <em>GRIN3A</em> rs10989692 variant was associated with osteonecrosis in both cohorts despite these underlying protocol differences.</p><p id="__p44">Glutamate receptor genetic variations have not been previously reported as risk factors for osteonecrosis. Glutamate is released by osteocytes in response to mechanical load, which opens stretch-sensitive calcium channels and causes activation of osteoblast receptors,<sup><a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775612">44</a></sup> and glutamate impairs endothelial barrier function.<sup><a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775613">45</a></sup> Glucocorticoids have been shown to induce the expression of glutamine synthetase in osteoblasts<sup><a href="#B46" rid="B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775648">46</a></sup> and hepatoma<sup><a href="#B47" rid="B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775615">47</a></sup> cells. Genetic variation in <em>GRIN3A</em> has been associated with the severity of vascular complications of Kawasaki disease.<sup><a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775610">48</a></sup> Interestingly, the disruption of the vascular supply to bone is a proximal event to glucocorticoid-induced osteonecrosis in a murine model, with or without asparaginase.<sup><a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_479775631">41</a></sup> Herein, in our PheWAS of <em>GRIN3A</em> SNPs, vascular phenotypes including cerebral ischemia, arterial embolism, and thrombosis trended toward association with glutamate receptor variants. Thus, glutamate and variations in glutamate receptors may contribute to a proximal vascular event that leads to an increased risk of osteonecrosis in individuals exposed to glucocorticoid therapy.</p><p id="__p45" class="p p-last">In conclusion, we hypothesize that different mechanisms of glucocorticoid-induced osteonecrosis may predominate among patients, influenced by variation in concurrent drug therapy as well as inherited genetic risk factors. To our knowledge, this is the largest genome-wide investigation of glucocorticoid-induced osteonecrosis. Our findings suggest for the first time a possible association between inherited genetic variations in glutamate receptors and the development of glucocorticoid-induced osteonecrosis in both ALL and non-ALL settings. The ability to identify genetic risk factors for osteonecrosis has implications for understanding the underlying mechanism of this common and serious adverse effect of glucocorticoids, and may have implications for modifying therapy decisions in the future.</p></div><div id="idm140585501653952" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140585501653952title">Acknowledgments</h2><div class="sec"><p id="__p48">This study was supported by the National Institutes of Health, Institute of General Medical Sciences, National Cancer Institute, Human Genome Research Institute, and National Library of Medicine grants GM 92666, GM 115279, <a id="__tag_780260045" class="tag_hotlink" href="/nuccore/CA142665" ref="/nuccore/CA142665"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA142665","term_id":"35037898","term_text":"CA142665"}}</span>CA142665</a>, CA 21765, CA 36401, CA98543 (COG Chair’s grant), CA98413 (COG Statistical Center), <a id="__tag_780260044" class="tag_hotlink" href="/nuccore/CA114766" ref="/nuccore/CA114766"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"CA114766","term_id":"34968073","term_text":"CA114766"}}</span>CA114766</a> (COG Specimen Banking), U01-HG04603, RC2-<a id="__tag_780260043" class="tag_hotlink" href="/nuccore/GM092618" ref="/nuccore/GM092618"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"GM092618","term_id":"221391163","term_text":"GM092618"}}</span>GM092618</a>, and R01-LM010685; the Vanderbilt Clinical Translational Science Award grants UL1-TR000445, 5T32-<a id="__tag_780260046" class="tag_hotlink" href="/nuccore/GM007569" ref="/nuccore/GM007569"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"GM007569","term_id":"218379808","term_text":"GM007569"}}</span>GM007569</a>, and LLS 6168; and the American Lebanese Syrian Associated Charities.</p></div></div><div id="idm140585501156800" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140585501156800title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140585501156672"></p><p id="__p46" class="p p-first-last">The online version of this article contains a data supplement.</p><p></p><p class="fn sec" id="idm140585495440096"></p><p id="__p47" class="p p-first-last">The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked “advertisement” in accordance with 18 USC section 1734.</p><p></p></div></div><div id="__sec15" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec15title">Authorship</h2><!--/article/back/sec/--><p id="__p49" class="p p-first">Contribution: E.A.R., C.-H.P., and M.V.R. were responsible for concept and design; S.L.V.D., S.K., E.B., D.M.R., J.C.D., E.L., N.W., M.L.L., S.P.H., P.S., M.D., L.A.M., and M.V.R. collected and assembled the data; W.Y., S.E.K., T.Y.C., M.B., L.B., D.M.R., J.C.D., W.L.C., C.C., D.P., C.A.F., C.L., C.S., P.S., S.J., W.E.E., M.D., L.A.M., and M.V.R. were responsible for the analysis and interpretation of data; and all authors contributed to the writing of the manuscript.</p><p id="__p50">Conflict-of-interest disclosure: The authors declare no competing financial interests.</p><p id="__p51" class="p p-last">Correspondence: Mary V. Relling, Pharmaceutical Department, St. Jude Children’s Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105; e-mail: <a href="mailto:dev@null" data-email="gro.edujts@gniller.yram" class="oemail">gro.edujts@gniller.yram</a>.</p></div><div id="idm140585500948224" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140585500948224title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="element-citation">Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">354</span>(2):166–178.</span> [<a href="/pubmed/16407512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Treatment+of+acute+lymphoblastic+leukemia.&amp;author=CH+Pui&amp;author=WE+Evans&amp;volume=354&amp;issue=2&amp;publication_year=2006&amp;pages=166-178&amp;pmid=16407512&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="element-citation">Pui CH, Campana D, Pei D, et al.  Treating childhood acute lymphoblastic leukemia without cranial irradiation. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>(26):2730–2741.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2754320/">PMC free article</a>]</span> [<a href="/pubmed/19553647" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Treating+childhood+acute+lymphoblastic+leukemia+without+cranial+irradiation.&amp;author=CH+Pui&amp;author=D+Campana&amp;author=D+Pei&amp;volume=360&amp;issue=26&amp;publication_year=2009&amp;pages=2730-2741&amp;pmid=19553647&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="element-citation">Hunger SP, Lu X, Devidas M, et al.  Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. <span><span class="ref-journal">J Clin Oncol. </span>2012;<span class="ref-vol">30</span>(14):1663–1669.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3383113/">PMC free article</a>]</span> [<a href="/pubmed/22412151" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Improved+survival+for+children+and+adolescents+with+acute+lymphoblastic+leukemia+between+1990+and+2005:+a+report+from+the+children’s+oncology+group.&amp;author=SP+Hunger&amp;author=X+Lu&amp;author=M+Devidas&amp;volume=30&amp;issue=14&amp;publication_year=2012&amp;pages=1663-1669&amp;pmid=22412151&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="element-citation">Schrappe M, Moricke A, Reiter A, et al.  Key treatment questions in childhood acute lymphoblastic leukemia: Results in 5 consecutive trials performed by the all-bfm study group from 1981 to 2000. <span><span class="ref-journal">Klin Padiatr. </span>2013;<span class="ref-vol">225</span>(suppl 1):S62–S72.</span> [<a href="/pubmed/23700060" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Klin+Padiatr&amp;title=Key+treatment+questions+in+childhood+acute+lymphoblastic+leukemia:+Results+in+5+consecutive+trials+performed+by+the+all-bfm+study+group+from+1981+to+2000.&amp;author=M+Schrappe&amp;author=A+Moricke&amp;author=A+Reiter&amp;volume=225&amp;issue=suppl+1&amp;publication_year=2013&amp;pages=S62-S72&amp;pmid=23700060&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="element-citation">Vora A, Goulden N, Mitchell C, et al.  Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. <span><span class="ref-journal">Lancet Oncol. </span>2014;<span class="ref-vol">15</span>(8):809–818.</span> [<a href="/pubmed/24924991" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;title=Augmented+post-remission+therapy+for+a+minimal+residual+disease-defined+high-risk+subgroup+of+children+and+young+people+with+clinical+standard-risk+and+intermediate-risk+acute+lymphoblastic+leukaemia+(UKALL+2003):+a+randomised+controlled+trial.&amp;author=A+Vora&amp;author=N+Goulden&amp;author=C+Mitchell&amp;volume=15&amp;issue=8&amp;publication_year=2014&amp;pages=809-818&amp;pmid=24924991&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="element-citation">Vaitkevičienė G, Forestier E, Hellebostad M, et al.  Nordic Society of Paediatric Haematology and Oncology (NOPHO) High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. <span><span class="ref-journal">Eur J Haematol. </span>2011;<span class="ref-vol">86</span>(1):38–46.</span> [<a href="/pubmed/21077959" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Haematol&amp;title=High+white+blood+cell+count+at+diagnosis+of+childhood+acute+lymphoblastic+leukaemia:+biological+background+and+prognostic+impact.+Results+from+the+NOPHO+ALL-92+and+ALL-2000+studies.&amp;author=G+Vaitkevičienė&amp;author=E+Forestier&amp;author=M+Hellebostad&amp;volume=86&amp;issue=1&amp;publication_year=2011&amp;pages=38-46&amp;pmid=21077959&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="element-citation">Kawedia JD, Kaste SC, Pei D, et al.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">117</span>(8):2340–2347, quiz 2556.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3062406/">PMC free article</a>]</span> [<a href="/pubmed/21148812" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Pharmacokinetic,+pharmacodynamic,+and+pharmacogenetic+determinants+of+osteonecrosis+in+children+with+acute+lymphoblastic+leukemia.&amp;author=JD+Kawedia&amp;author=SC+Kaste&amp;author=D+Pei&amp;volume=117&amp;issue=8&amp;publication_year=2011&amp;pages=2340-2347,+quiz+2556&amp;pmid=21148812&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="element-citation">Mattano LA, Jr, Devidas M, Nachman JB, et al.  Children’s Oncology Group. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. <span><span class="ref-journal">Lancet Oncol. </span>2012;<span class="ref-vol">13</span>(9):906–915.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3448283/">PMC free article</a>]</span> [<a href="/pubmed/22901620" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;title=Effect+of+alternate-week+versus+continuous+dexamethasone+scheduling+on+the+risk+of+osteonecrosis+in+paediatric+patients+with+acute+lymphoblastic+leukaemia:+results+from+the+CCG-1961+randomised+cohort+trial.&amp;author=LA+Mattano&amp;author=M+Devidas&amp;author=JB+Nachman&amp;volume=13&amp;issue=9&amp;publication_year=2012&amp;pages=906-915&amp;pmid=22901620&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="element-citation">Patel B, Richards SM, Rowe JM, Goldstone AH, Fielding AK. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. <span><span class="ref-journal">Leukemia. </span>2008;<span class="ref-vol">22</span>(2):308–312.</span> [<a href="/pubmed/17989709" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=High+incidence+of+avascular+necrosis+in+adolescents+with+acute+lymphoblastic+leukaemia:+a+UKALL+XII+analysis.&amp;author=B+Patel&amp;author=SM+Richards&amp;author=JM+Rowe&amp;author=AH+Goldstone&amp;author=AK+Fielding&amp;volume=22&amp;issue=2&amp;publication_year=2008&amp;pages=308-312&amp;pmid=17989709&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="element-citation">Relling MV, Yang W, Das S, et al.  Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2004;<span class="ref-vol">22</span>(19):3930–3936.</span> [<a href="/pubmed/15459215" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Pharmacogenetic+risk+factors+for+osteonecrosis+of+the+hip+among+children+with+leukemia.&amp;author=MV+Relling&amp;author=W+Yang&amp;author=S+Das&amp;volume=22&amp;issue=19&amp;publication_year=2004&amp;pages=3930-3936&amp;pmid=15459215&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="element-citation">Mattano LA, Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Group. <span><span class="ref-journal">J Clin Oncol. </span>2000;<span class="ref-vol">18</span>(18):3262–3272.</span> [<a href="/pubmed/10986059" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Osteonecrosis+as+a+complication+of+treating+acute+lymphoblastic+leukemia+in+children:+a+report+from+the+Children’s+Cancer+Group.&amp;author=LA+Mattano&amp;author=HN+Sather&amp;author=ME+Trigg&amp;author=JB+Nachman&amp;volume=18&amp;issue=18&amp;publication_year=2000&amp;pages=3262-3272&amp;pmid=10986059&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="element-citation">te Winkel ML, Pieters R, Hop WC, et al.  Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2011;<span class="ref-vol">29</span>(31):4143–4150.</span> [<a href="/pubmed/21947829" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Prospective+study+on+incidence,+risk+factors,+and+long-term+outcome+of+osteonecrosis+in+pediatric+acute+lymphoblastic+leukemia.&amp;author=ML+te+Winkel&amp;author=R+Pieters&amp;author=WC+Hop&amp;volume=29&amp;issue=31&amp;publication_year=2011&amp;pages=4143-4150&amp;pmid=21947829&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="element-citation">Drescher W, Schlieper G, Floege J, Eitner F. Steroid-related osteonecrosis--an update. <span><span class="ref-journal">Nephrol Dial Transplant. </span>2011;<span class="ref-vol">26</span>(9):2728–2731.</span> [<a href="/pubmed/21602181" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol+Dial+Transplant&amp;title=Steroid-related+osteonecrosis--an+update.&amp;author=W+Drescher&amp;author=G+Schlieper&amp;author=J+Floege&amp;author=F+Eitner&amp;volume=26&amp;issue=9&amp;publication_year=2011&amp;pages=2728-2731&amp;pmid=21602181&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="element-citation">Shigemura T, Nakamura J, Kishida S, et al.  Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. <span><span class="ref-journal">Rheumatology (Oxford) </span>2011;<span class="ref-vol">50</span>(11):2023–2028.</span> [<a href="/pubmed/21865285" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology+(Oxford)&amp;title=Incidence+of+osteonecrosis+associated+with+corticosteroid+therapy+among+different+underlying+diseases:+prospective+MRI+study.&amp;author=T+Shigemura&amp;author=J+Nakamura&amp;author=S+Kishida&amp;volume=50&amp;issue=11&amp;publication_year=2011&amp;pages=2023-2028&amp;pmid=21865285&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="element-citation">Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME. Steroid induced osteonecrosis: an analysis of steroid dosing risk. <span><span class="ref-journal">Autoimmun Rev. </span>2010;<span class="ref-vol">9</span>(11):721–743.</span> [<a href="/pubmed/20621176" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmun+Rev&amp;title=Steroid+induced+osteonecrosis:+an+analysis+of+steroid+dosing+risk.&amp;author=C+Powell&amp;author=C+Chang&amp;author=SM+Naguwa&amp;author=G+Cheema&amp;author=ME+Gershwin&amp;volume=9&amp;issue=11&amp;publication_year=2010&amp;pages=721-743&amp;pmid=20621176&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="element-citation">Roden DM, Pulley JM, Basford MA, et al.  Development of a large-scale de-identified DNA biobank to enable personalized medicine. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2008;<span class="ref-vol">84</span>(3):362–369.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3763939/">PMC free article</a>]</span> [<a href="/pubmed/18500243" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Development+of+a+large-scale+de-identified+DNA+biobank+to+enable+personalized+medicine.&amp;author=DM+Roden&amp;author=JM+Pulley&amp;author=MA+Basford&amp;volume=84&amp;issue=3&amp;publication_year=2008&amp;pages=362-369&amp;pmid=18500243&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="element-citation">Pulley J, Clayton E, Bernard GR, Roden DM, Masys DR. Principles of human subjects protections applied in an opt-out, de-identified biobank. <span><span class="ref-journal">Clin Transl Sci. </span>2010;<span class="ref-vol">3</span>(1):42–48.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3075971/">PMC free article</a>]</span> [<a href="/pubmed/20443953" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Transl+Sci&amp;title=Principles+of+human+subjects+protections+applied+in+an+opt-out,+de-identified+biobank.&amp;author=J+Pulley&amp;author=E+Clayton&amp;author=GR+Bernard&amp;author=DM+Roden&amp;author=DR+Masys&amp;volume=3&amp;issue=1&amp;publication_year=2010&amp;pages=42-48&amp;pmid=20443953&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="element-citation">Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">78</span>(4):629–644.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1424677/">PMC free article</a>]</span> [<a href="/pubmed/16532393" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=A+fast+and+flexible+statistical+model+for+large-scale+population+genotype+data:+applications+to+inferring+missing+genotypes+and+haplotypic+phase.&amp;author=P+Scheet&amp;author=M+Stephens&amp;volume=78&amp;issue=4&amp;publication_year=2006&amp;pages=629-644&amp;pmid=16532393&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="element-citation">Liu EY, Li M, Wang W, Li Y. MaCH-admix: genotype imputation for admixed populations. <span><span class="ref-journal">Genet Epidemiol. </span>2013;<span class="ref-vol">37</span>(1):25–37.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3524415/">PMC free article</a>]</span> [<a href="/pubmed/23074066" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genet+Epidemiol&amp;title=MaCH-admix:+genotype+imputation+for+admixed+populations.&amp;author=EY+Liu&amp;author=M+Li&amp;author=W+Wang&amp;author=Y+Li&amp;volume=37&amp;issue=1&amp;publication_year=2013&amp;pages=25-37&amp;pmid=23074066&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="element-citation">Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>(6):e1000529.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2689936/">PMC free article</a>]</span> [<a href="/pubmed/19543373" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=A+flexible+and+accurate+genotype+imputation+method+for+the+next+generation+of+genome-wide+association+studies.&amp;author=BN+Howie&amp;author=P+Donnelly&amp;author=J+Marchini&amp;volume=5&amp;issue=6&amp;publication_year=2009&amp;pages=e1000529&amp;pmid=19543373&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="element-citation">Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. <span><span class="ref-journal">Genetics. </span>2000;<span class="ref-vol">155</span>(2):945–959.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1461096/">PMC free article</a>]</span> [<a href="/pubmed/10835412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Inference+of+population+structure+using+multilocus+genotype+data.&amp;author=JK+Pritchard&amp;author=M+Stephens&amp;author=P+Donnelly&amp;volume=155&amp;issue=2&amp;publication_year=2000&amp;pages=945-959&amp;pmid=10835412&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="element-citation">Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. <span><span class="ref-journal">Bioinformatics. </span>2010;<span class="ref-vol">26</span>(17):2190–2191.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2922887/">PMC free article</a>]</span> [<a href="/pubmed/20616382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=METAL:+fast+and+efficient+meta-analysis+of+genomewide+association+scans.&amp;author=CJ+Willer&amp;author=Y+Li&amp;author=GR+Abecasis&amp;volume=26&amp;issue=17&amp;publication_year=2010&amp;pages=2190-2191&amp;pmid=20616382&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="element-citation">Denny JC, Ritchie MD, Basford MA, et al.  PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. <span><span class="ref-journal">Bioinformatics. </span>2010;<span class="ref-vol">26</span>(9):1205–1210.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2859132/">PMC free article</a>]</span> [<a href="/pubmed/20335276" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=PheWAS:+demonstrating+the+feasibility+of+a+phenome-wide+scan+to+discover+gene-disease+associations.&amp;author=JC+Denny&amp;author=MD+Ritchie&amp;author=MA+Basford&amp;volume=26&amp;issue=9&amp;publication_year=2010&amp;pages=1205-1210&amp;pmid=20335276&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="element-citation">Denny JC, Bastarache L, Ritchie MD, et al.  Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. <span><span class="ref-journal">Nat Biotechnol. </span>2013;<span class="ref-vol">31</span>(12):1102–1110.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3969265/">PMC free article</a>]</span> [<a href="/pubmed/24270849" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=Systematic+comparison+of+phenome-wide+association+study+of+electronic+medical+record+data+and+genome-wide+association+study+data.&amp;author=JC+Denny&amp;author=L+Bastarache&amp;author=MD+Ritchie&amp;volume=31&amp;issue=12&amp;publication_year=2013&amp;pages=1102-1110&amp;pmid=24270849&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="element-citation">Chang T, Yang W, Sara VDL, et al.  Glutamate receptor polymorphisms contribute to glucocorticoid-associated osteonecrosis. <span><span class="ref-journal">Blood. </span>2014;<span class="ref-vol">124</span>(21):367.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Glutamate+receptor+polymorphisms+contribute+to+glucocorticoid-associated+osteonecrosis.&amp;author=T+Chang&amp;author=W+Yang&amp;author=VDL+Sara&amp;volume=124&amp;issue=21&amp;publication_year=2014&amp;pages=367&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="element-citation">Mirkov S, Myers JL, Ramírez J, Liu W. SNPs affecting serum metabolomic traits may regulate gene transcription and lipid accumulation in the liver. <span><span class="ref-journal">Metabolism. </span>2012;<span class="ref-vol">61</span>(11):1523–1527.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3867007/">PMC free article</a>]</span> [<a href="/pubmed/22738862" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Metabolism&amp;title=SNPs+affecting+serum+metabolomic+traits+may+regulate+gene+transcription+and+lipid+accumulation+in+the+liver.&amp;author=S+Mirkov&amp;author=JL+Myers&amp;author=J+Ramírez&amp;author=W+Liu&amp;volume=61&amp;issue=11&amp;publication_year=2012&amp;pages=1523-1527&amp;pmid=22738862&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="element-citation">Zhou J, Ye S, Fujiwara T, Manolagas SC, Zhao H. Steap4 plays a critical role in osteoclastogenesis in vitro by regulating cellular iron/reactive oxygen species (ROS) levels and cAMP response element-binding protein (CREB) activation. <span><span class="ref-journal">J Biol Chem. </span>2013;<span class="ref-vol">288</span>(42):30064–30074.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3798475/">PMC free article</a>]</span> [<a href="/pubmed/23990467" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Steap4+plays+a+critical+role+in+osteoclastogenesis+in+vitro+by+regulating+cellular+iron/reactive+oxygen+species+(ROS)+levels+and+cAMP+response+element-binding+protein+(CREB)+activation.&amp;author=J+Zhou&amp;author=S+Ye&amp;author=T+Fujiwara&amp;author=SC+Manolagas&amp;author=H+Zhao&amp;volume=288&amp;issue=42&amp;publication_year=2013&amp;pages=30064-30074&amp;pmid=23990467&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="element-citation">Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur SV, Welsh JE. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. <span><span class="ref-journal">J Cell Physiol. </span>2013;<span class="ref-vol">228</span>(10):2024–2036.</span> [<a href="/pubmed/23553608" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Physiol&amp;title=Induction+of+STEAP4+correlates+with+1,25-dihydroxyvitamin+D3+stimulation+of+adipogenesis+in+mesenchymal+progenitor+cells+derived+from+human+adipose+tissue.&amp;author=CJ+Narvaez&amp;author=KM+Simmons&amp;author=J+Brunton&amp;author=A+Salinero&amp;author=SV+Chittur&amp;volume=228&amp;issue=10&amp;publication_year=2013&amp;pages=2024-2036&amp;pmid=23553608&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="element-citation">Martin RI, Owens WA, Cunnington MS, Mayosi BM, Koref MS, Keavney BD. Chromosome 16q22 variants in a region associated with cardiovascular phenotypes correlate with ZFHX3 expression in a transcript-specific manner. <span><span class="ref-journal">BMC Genet. </span>2014;<span class="ref-vol">15</span>(1):136.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4301889/">PMC free article</a>]</span> [<a href="/pubmed/25539802" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Genet&amp;title=Chromosome+16q22+variants+in+a+region+associated+with+cardiovascular+phenotypes+correlate+with+ZFHX3+expression+in+a+transcript-specific+manner.&amp;author=RI+Martin&amp;author=WA+Owens&amp;author=MS+Cunnington&amp;author=BM+Mayosi&amp;author=MS+Koref&amp;volume=15&amp;issue=1&amp;publication_year=2014&amp;pages=136&amp;pmid=25539802&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="element-citation">Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. <span><span class="ref-journal">Rheumatology (Oxford) </span>2014;<span class="ref-vol">53</span>(8):1470–1476.</span> [<a href="/pubmed/24681836" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rheumatology+(Oxford)&amp;title=Glucocorticoids+and+irreversible+damage+in+patients+with+systemic+lupus+erythematosus.&amp;author=I+Ruiz-Arruza&amp;author=A+Ugarte&amp;author=I+Cabezas-Rodriguez&amp;author=JA+Medina&amp;author=MA+Moran&amp;volume=53&amp;issue=8&amp;publication_year=2014&amp;pages=1470-1476&amp;pmid=24681836&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="element-citation">Kamata N, Oshitani N, Sogawa M, et al.  Usefulness of magnetic resonance imaging for detection of asymptomatic osteonecrosis of the femoral head in patients with inflammatory bowel disease on long-term corticosteroid treatment. <span><span class="ref-journal">Scand J Gastroenterol. </span>2008;<span class="ref-vol">43</span>(3):308–313.</span> [<a href="/pubmed/18938768" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Scand+J+Gastroenterol&amp;title=Usefulness+of+magnetic+resonance+imaging+for+detection+of+asymptomatic+osteonecrosis+of+the+femoral+head+in+patients+with+inflammatory+bowel+disease+on+long-term+corticosteroid+treatment.&amp;author=N+Kamata&amp;author=N+Oshitani&amp;author=M+Sogawa&amp;volume=43&amp;issue=3&amp;publication_year=2008&amp;pages=308-313&amp;pmid=18938768&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="element-citation">Chen SH, Pei D, Yang W, et al.  Genetic variations in GRIA1 on chromosome 5q33 related to asparaginase hypersensitivity. <span><span class="ref-journal">Clin Pharmacol Ther. </span>2010;<span class="ref-vol">88</span>(2):191–196.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3000799/">PMC free article</a>]</span> [<a href="/pubmed/20592726" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=Genetic+variations+in+GRIA1+on+chromosome+5q33+related+to+asparaginase+hypersensitivity.&amp;author=SH+Chen&amp;author=D+Pei&amp;author=W+Yang&amp;volume=88&amp;issue=2&amp;publication_year=2010&amp;pages=191-196&amp;pmid=20592726&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="element-citation">Rajic V, Debeljak M, Goricar K, Jazbec J. Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia [published online ahead of print March 30, 2015]. <span><span class="ref-journal">Leuk Lymphoma. </span>2015:1–6.</span> [<a href="/pubmed/25697915" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leuk+Lymphoma&amp;title=Polymorphisms+in+GRIA1+gene+are+a+risk+factor+for+asparaginase+hypersensitivity+during+the+treatment+of+childhood+acute+lymphoblastic+leukemia+[published+online+ahead+of+print+March+30,+2015].&amp;author=V+Rajic&amp;author=M+Debeljak&amp;author=K+Goricar&amp;author=J+Jazbec&amp;publication_year=2015&amp;pages=1-6&amp;pmid=25697915&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="element-citation">Yang L, Panetta JC, Cai X, et al.  Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>(12):1932–1939.</span> [<a href="/pubmed/18421047" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Asparaginase+may+influence+dexamethasone+pharmacokinetics+in+acute+lymphoblastic+leukemia.&amp;author=L+Yang&amp;author=JC+Panetta&amp;author=X+Cai&amp;volume=26&amp;issue=12&amp;publication_year=2008&amp;pages=1932-1939&amp;pmid=18421047&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="element-citation">Liu C, Kawedia JD, Cheng C, et al.  Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. <span><span class="ref-journal">Leukemia. </span>2012;<span class="ref-vol">26</span>(11):2303–2309.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3516853/">PMC free article</a>]</span> [<a href="/pubmed/22484422" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Clinical+utility+and+implications+of+asparaginase+antibodies+in+acute+lymphoblastic+leukemia.&amp;author=C+Liu&amp;author=JD+Kawedia&amp;author=C+Cheng&amp;volume=26&amp;issue=11&amp;publication_year=2012&amp;pages=2303-2309&amp;pmid=22484422&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="element-citation">Smith RW, Margulis RR, Brennan MJ, Monto RW. The influence of ACTH and cortisone on certain factors of blood coagulation. <span><span class="ref-journal">Science. </span>1950;<span class="ref-vol">112</span>(2907):295–297.</span> [<a href="/pubmed/14781730" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+influence+of+ACTH+and+cortisone+on+certain+factors+of+blood+coagulation.&amp;author=RW+Smith&amp;author=RR+Margulis&amp;author=MJ+Brennan&amp;author=RW+Monto&amp;volume=112&amp;issue=2907&amp;publication_year=1950&amp;pages=295-297&amp;pmid=14781730&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="element-citation">Yamamoto T, Hirano K, Tsutsui H, Sugioka Y, Sueishi K. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction. <span><span class="ref-journal">Clin Orthop Relat Res. </span>1995;(316):235–243.</span> [<a href="/pubmed/7634712" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Orthop+Relat+Res&amp;title=Corticosteroid+enhances+the+experimental+induction+of+osteonecrosis+in+rabbits+with+Shwartzman+reaction.&amp;author=T+Yamamoto&amp;author=K+Hirano&amp;author=H+Tsutsui&amp;author=Y+Sugioka&amp;author=K+Sueishi&amp;issue=316&amp;publication_year=1995&amp;pages=235-243&amp;pmid=7634712&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="element-citation">Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. <span><span class="ref-journal">Arthritis Rheum. </span>1997;<span class="ref-vol">40</span>(11):2055–2064.</span> [<a href="/pubmed/9365096" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=Effects+of+pulse+methylprednisolone+on+bone+and+marrow+tissues:+corticosteroid-induced+osteonecrosis+in+rabbits.&amp;author=T+Yamamoto&amp;author=T+Irisa&amp;author=Y+Sugioka&amp;author=K+Sueishi&amp;volume=40&amp;issue=11&amp;publication_year=1997&amp;pages=2055-2064&amp;pmid=9365096&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="element-citation">Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. <span><span class="ref-journal">Clin Orthop Relat Res. </span>2001;(386):19–33.</span> [<a href="/pubmed/11347834" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Orthop+Relat+Res&amp;title=Hypofibrinolysis,+thrombophilia,+osteonecrosis.&amp;author=CJ+Glueck&amp;author=RA+Freiberg&amp;author=RN+Fontaine&amp;author=T+Tracy&amp;author=P+Wang&amp;issue=386&amp;publication_year=2001&amp;pages=19-33&amp;pmid=11347834&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="element-citation">Yun SI, Yoon HY, Jeong SY, Chung YS. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. <span><span class="ref-journal">J Bone Miner Metab. </span>2009;<span class="ref-vol">27</span>(2):140–148.</span> [<a href="/pubmed/19066717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Metab&amp;title=Glucocorticoid+induces+apoptosis+of+osteoblast+cells+through+the+activation+of+glycogen+synthase+kinase+3beta.&amp;author=SI+Yun&amp;author=HY+Yoon&amp;author=SY+Jeong&amp;author=YS+Chung&amp;volume=27&amp;issue=2&amp;publication_year=2009&amp;pages=140-148&amp;pmid=19066717&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="element-citation">Janke LJ, Liu C, Vogel P, et al.  Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis. <span><span class="ref-journal">Am J Pathol. </span>2013;<span class="ref-vol">183</span>(1):19–25.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3702740/">PMC free article</a>]</span> [<a href="/pubmed/23673001" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;title=Primary+epiphyseal+arteriopathy+in+a+mouse+model+of+steroid-induced+osteonecrosis.&amp;author=LJ+Janke&amp;author=C+Liu&amp;author=P+Vogel&amp;volume=183&amp;issue=1&amp;publication_year=2013&amp;pages=19-25&amp;pmid=23673001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="element-citation">French D, Hamilton LH, Mattano LA, Jr, et al.  Children’s Oncology Group. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children’s Oncology Group. <span><span class="ref-journal">Blood. </span>2008;<span class="ref-vol">111</span>(9):4496–4499.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2343589/">PMC free article</a>]</span> [<a href="/pubmed/18285546" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=A+PAI-1+(SERPINE1)+polymorphism+predicts+osteonecrosis+in+children+with+acute+lymphoblastic+leukemia:+a+report+from+the+Children’s+Oncology+Group.&amp;author=D+French&amp;author=LH+Hamilton&amp;author=LA+Mattano&amp;volume=111&amp;issue=9&amp;publication_year=2008&amp;pages=4496-4499&amp;pmid=18285546&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="element-citation">Bond J, Adams S, Richards S, Vora A, Mitchell C, Goulden N. Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia. <span><span class="ref-journal">Blood. </span>2011;<span class="ref-vol">118</span>(9):2632–2633.</span> [<a href="/pubmed/21885611" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Polymorphism+in+the+PAI-1+(SERPINE1)+gene+and+the+risk+of+osteonecrosis+in+children+with+acute+lymphoblastic+leukemia.&amp;author=J+Bond&amp;author=S+Adams&amp;author=S+Richards&amp;author=A+Vora&amp;author=C+Mitchell&amp;volume=118&amp;issue=9&amp;publication_year=2011&amp;pages=2632-2633&amp;pmid=21885611&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="element-citation">Brakspear KS, Mason DJ. Glutamate signaling in bone. <span><span class="ref-journal">Front Endocrinol (Lausanne) </span>2012;<span class="ref-vol">3</span>:97.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3412269/">PMC free article</a>]</span> [<a href="/pubmed/22888325" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Endocrinol+(Lausanne)&amp;title=Glutamate+signaling+in+bone.&amp;author=KS+Brakspear&amp;author=DJ+Mason&amp;volume=3&amp;publication_year=2012&amp;pages=97&amp;pmid=22888325&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="element-citation">Sharp CD, Houghton J, Elrod JW, et al.  N-methyl-D-aspartate receptor activation in human cerebral endothelium promotes intracellular oxidant stress. <span><span class="ref-journal">Am J Physiol Heart Circ Physiol. </span>2005;<span class="ref-vol">288</span>(4):H1893–H1899.</span> [<a href="/pubmed/15576430" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Physiol+Heart+Circ+Physiol&amp;title=N-methyl-D-aspartate+receptor+activation+in+human+cerebral+endothelium+promotes+intracellular+oxidant+stress.&amp;author=CD+Sharp&amp;author=J+Houghton&amp;author=JW+Elrod&amp;volume=288&amp;issue=4&amp;publication_year=2005&amp;pages=H1893-H1899&amp;pmid=15576430&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="element-citation">Olkku A, Bodine PV, Linnala-Kankkunen A, Mahonen A. Glucocorticoids induce glutamine synthetase expression in human osteoblastic cells: a novel observation in bone. <span><span class="ref-journal">Bone. </span>2004;<span class="ref-vol">34</span>(2):320–329.</span> [<a href="/pubmed/14962810" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bone&amp;title=Glucocorticoids+induce+glutamine+synthetase+expression+in+human+osteoblastic+cells:+a+novel+observation+in+bone.&amp;author=A+Olkku&amp;author=PV+Bodine&amp;author=A+Linnala-Kankkunen&amp;author=A+Mahonen&amp;volume=34&amp;issue=2&amp;publication_year=2004&amp;pages=320-329&amp;pmid=14962810&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="element-citation">Gaunitz F, Heise K, Schumann R, Gebhardt R. Glucocorticoid induced expression of glutamine synthetase in hepatoma cells. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2002;<span class="ref-vol">296</span>(4):1026–1032.</span> [<a href="/pubmed/12200152" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Glucocorticoid+induced+expression+of+glutamine+synthetase+in+hepatoma+cells.&amp;author=F+Gaunitz&amp;author=K+Heise&amp;author=R+Schumann&amp;author=R+Gebhardt&amp;volume=296&amp;issue=4&amp;publication_year=2002&amp;pages=1026-1032&amp;pmid=12200152&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="element-citation">Lin YJ, Chang JS, Liu X, et al.  Association between GRIN3A gene polymorphism in Kawasaki disease and coronary artery aneurysms in Taiwanese children. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>(11):e81384.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3838481/">PMC free article</a>]</span> [<a href="/pubmed/24278430" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Association+between+GRIN3A+gene+polymorphism+in+Kawasaki+disease+and+coronary+artery+aneurysms+in+Taiwanese+children.&amp;author=YJ+Lin&amp;author=JS+Chang&amp;author=X+Liu&amp;volume=8&amp;issue=11&amp;publication_year=2013&amp;pages=e81384&amp;pmid=24278430&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4600016&amp;issue-id=259000&amp;journal-id=446&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm140585499490224title">Key Points</a></li><li><a href="#idm140585499893792title">Abstract</a></li><li><a href="#__sec1title">Introduction</a></li><li><a href="#__sec2title">Methods</a></li><li><a href="#__sec9title">Results</a></li><li><a href="#__sec14title">Discussion</a></li><li><a href="#idm140585501653952title">Acknowledgments</a></li><li><a href="#idm140585501156800title">Footnotes</a></li><li><a href="#__sec15title">Authorship</a></li><li><a href="#idm140585500948224title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Blood</span> are provided here courtesy of <strong>The American Society of Hematology</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4600016/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4600016/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4600016/?report=printable">Printer Friendly</a></li> | <li><a href="#" data-citationid="PMC4600016" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4600016%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4600016%2F&amp;text=Genetics%20of%20glucocorticoid-associated%20osteonecrosis%20in%20children%20with%20acute%20lymphoblastic%20leukemia" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4600016%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="26265699" data-aiid="4600016" data-aid="4600016" data-iid="259000" data-domainid="446" data-domain="blood" data-accid="PMC4600016" data-md5="2f047d575d37a8aa06cefee7cceb6176"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T13:56:54-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal101&amp;ncbi_phid=CE888247DD5830410000000006A003D9&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4600016%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=blood&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4600016/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>